Research Article

Evaluation of herbal medicine use in Chronic Kidney Disease

Volume: 8 Number: 3 September 1, 2022
  • Feyza Bora
  • Emine Asar
  • Esin Avşar
  • Hasan Sözel
  • Fatih Yılmaz *
EN TR

Evaluation of herbal medicine use in Chronic Kidney Disease

Abstract

ABSTRACT Background One of the causes of chronic kidney disease (CKD) may be nephrotoxic herbal products. We wanted to ascertain the rate of herbal product use among these CKD patients, the products used, sources of supply, demographic characteristics of the patients, whether acute renal failure develops with these products and the value of predialysis education in this field. Methods The data of 209 patients were collected at the nephrology department and evaluated using a form completed by a CKD education specialist nurse in one-to-one patient interviews. Results The patients’ mean age was 57.3 years, and 41% were female. 22% of the patients (n=45) used herbal products. Seven patients followed up with stable GFR had an acute kidney injury episode after using herbal products. The herbal product names used by the patients were as follows: unknown weed mix, black cumin oil, cherry stalk, rosemary, cinnamon, Helichrysum Arenarium, spring water, Galium aparine, reishi mushroom, Ceratonia siliqua, daisy, snail shell, Viburnum opulus, onion juice, Stevia rebaudiana Bertoni, cranberry, malus trilobata leaf, avocado leaf, fig and olive leaf, horse chestnut, ginger, urtica leaf, eating walnut after soaking it in water, pumpkin seed, Vitex agnus-castus, aloe vera, blueberries, juniper molasses, Equisetum arvense L, Lamii albi herba1, yoghurt water. The patients who were followed for more than six months tended to report their herbal product use more than the remaining patients (p = 0.08). Conclusion Due to the widespread use of herbal products, clinicians should be more careful about the use of herbal products by patients. Key words: Chronic Kidney Disease, Herbal Medicine, Education, Communication

Keywords

References

  1. 1. Jha V. Herbal medicines and chronic kidney disease. Nephrology (Carlton) 2010; 15 Suppl 2:10–17.
  2. 2. Isnard Bagnis C, Crepaldi C, Dean J, Goovaerts T, Melander S, Nilsson EL, Prieto-Velasco M, Trujillo C, Zambon R, Mooney A. Quality standards for predialysis education: results from a consensus conference. Nephrol Dial Transplant. 2015;30(7):1058-66. doi: 10.1093/ndt/gfu225. Epub 2014 Jun 23.
  3. 3. Ludlow MJ, Lauder LA, Mathew TH, Hawley CM, Fortnum D. Australian consumer perspectives on dialysis: first national census. Nephrology (Carlton). 2012;17(8):703-709.
  4. 4. Thorne SE, Robinson CA. Reciprocal trust in health care relationships. J Adv Nurs .1988;13(6):782-9.
  5. 5. Eriksson I, Nilsson K. Preconditions needed for establishing a trusting relationship during health counselling - an interview study. J Clin Nurs. 2008;17(17):2352-2359.
  6. 6. Louise Shepherd M. Behind the scales:Child and family health nurses taking care of women’s emotional wellbeing. Contemp Nurse. 2011 17;37(2):137-148.
  7. 7. Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis. 2014;63(5):713-35. doi: 10.1053/j.ajkd.2014.01.416. Epub 2014 Mar 16.
  8. 8. Bardia A, Nisly NL, Zimmerman MB, Gryzlak BM, Wallace RB. Use of herbs among adults based on evidence-based indications: findings from the National Health Interview Survey. Mayo Clin Proc. 2007;82(5):561-566.

Details

Primary Language

English

Subjects

Clinical Sciences

Journal Section

Research Article

Publication Date

September 1, 2022

Submission Date

April 2, 2021

Acceptance Date

July 1, 2021

Published in Issue

Year 2022 Volume: 8 Number: 3

APA
Bora, F., Asar, E., Avşar, E., Sözel, H., & Yılmaz, F. (2022). Evaluation of herbal medicine use in Chronic Kidney Disease. Akdeniz Tıp Dergisi, 8(3), 319-325. https://doi.org/10.53394/akd.1059440
AMA
1.Bora F, Asar E, Avşar E, Sözel H, Yılmaz F. Evaluation of herbal medicine use in Chronic Kidney Disease. Akd Med J. 2022;8(3):319-325. doi:10.53394/akd.1059440
Chicago
Bora, Feyza, Emine Asar, Esin Avşar, Hasan Sözel, and Fatih Yılmaz. 2022. “Evaluation of Herbal Medicine Use in Chronic Kidney Disease”. Akdeniz Tıp Dergisi 8 (3): 319-25. https://doi.org/10.53394/akd.1059440.
EndNote
Bora F, Asar E, Avşar E, Sözel H, Yılmaz F (September 1, 2022) Evaluation of herbal medicine use in Chronic Kidney Disease. Akdeniz Tıp Dergisi 8 3 319–325.
IEEE
[1]F. Bora, E. Asar, E. Avşar, H. Sözel, and F. Yılmaz, “Evaluation of herbal medicine use in Chronic Kidney Disease”, Akd Med J, vol. 8, no. 3, pp. 319–325, Sept. 2022, doi: 10.53394/akd.1059440.
ISNAD
Bora, Feyza - Asar, Emine - Avşar, Esin - Sözel, Hasan - Yılmaz, Fatih. “Evaluation of Herbal Medicine Use in Chronic Kidney Disease”. Akdeniz Tıp Dergisi 8/3 (September 1, 2022): 319-325. https://doi.org/10.53394/akd.1059440.
JAMA
1.Bora F, Asar E, Avşar E, Sözel H, Yılmaz F. Evaluation of herbal medicine use in Chronic Kidney Disease. Akd Med J. 2022;8:319–325.
MLA
Bora, Feyza, et al. “Evaluation of Herbal Medicine Use in Chronic Kidney Disease”. Akdeniz Tıp Dergisi, vol. 8, no. 3, Sept. 2022, pp. 319-25, doi:10.53394/akd.1059440.
Vancouver
1.Feyza Bora, Emine Asar, Esin Avşar, Hasan Sözel, Fatih Yılmaz. Evaluation of herbal medicine use in Chronic Kidney Disease. Akd Med J. 2022 Sep. 1;8(3):319-25. doi:10.53394/akd.1059440